Review Article
Hypofractionation in prostate cancer radiotherapy
Translational Cancer Research
2018;
7
(Suppl 6)
:S632-S639
.
(30 July 2018)
Genetic signatures on prostate biopsy: clinical implications
Translational Cancer Research
2018;
7
(Suppl 6)
:S640-S650
.
(30 July 2018)
Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management
Translational Cancer Research
2018;
7
(Suppl 6)
:S651-S661
.
(30 July 2018)
Neoadjuvant therapies for surgical management of high risk, localized prostate cancer
Translational Cancer Research
2018;
7
(Suppl 6)
:S662-S675
.
(30 July 2018)
Prostate-specific membrane antigen in prostate cancer imaging and treatment
Translational Cancer Research
2018;
7
(Suppl 6)
:S676-S689
.
(30 July 2018)
2nd generation anti-androgens and radiotherapy for localized prostate cancer
Translational Cancer Research
2018;
7
(Suppl 6)
:S690-S694
.
(30 July 2018)
Androgen deprivation therapy and radiation therapy for prostate cancer: the mechanism underlying therapeutic synergy
Translational Cancer Research
2018;
7
(Suppl 6)
:S695-S703
.
(30 July 2018)
Editorial
Genetic signatures on radical prostatectomy specimens: clinical implications
Translational Cancer Research
2018;
7
(Suppl 6)
:S704-S710
.
(30 July 2018)
Disclosure:
The supplement “Prostate Cancer: Current Understanding and Future Directions” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Israel Deutsch, Charles G Drake and James McKiernan served as the unpaid Guest Editors for the supplement.
